Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

CNBC

BusinessCNBC·Jul 29, 2026·1 min read

Why shareholders are suing Novo Nordisk over next-generation weight-loss drug

Investors claim Novo Nordisk misled the market about CagriSema's tolerability, after disappointing clinical trial results wiped billions off its market cap.

View original source — CNBC ↗

ShareShare on X Share on Facebook

Related stories

BusinessJul 29, 2026 · 1 min

Ireland unveils blueprint to electrify economy by 2050

BusinessJul 29, 2026 · 1 min

AI Spending In Focus for Meta, Microsoft Earnings

Argentina snaps dollar-buying streak day after IMF hailed policy

Buenos Aires Times

BusinessJul 29, 2026 · 1 min

Argentina snaps dollar-buying streak day after IMF hailed policy

Buenos Aires Times

BusinessJul 29, 2026 · 1 min

Will AI Consume Investors' Risk Budget?